PROCEPT BioRobotics (PRCT) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on PROCEPT BioRobotics (PRCT) is Moderate Underperform.

The composite score behind that read is -0.24, weighing +0.13 of bullish evidence against -0.33 bearish.

PROCEPT BioRobotics last closed at $17.82, +3.85% on the session.

Against the IVW growth benchmark the position is +2.93% over the forecast window.

The read is built from 12 underlying insights — 2 bullish and 10 bearish.

Agreement across those insights is 83%.

16 graded predictions for PRCT so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks PROCEPT BioRobotics in the 23rd percentile on return on equity, where 100 is best.

PROCEPT BioRobotics is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $982.82M.

StockMap tracks PROCEPT BioRobotics as the 62nd largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite PROCEPT BioRobotics ranks 85th of 133 in the group, against a group median of -0.21.